A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney Transplantation

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
Kidney Transplantation
Interventions
DRUG

FK506MR

oral

DRUG

Prograf

oral

DRUG

Mycophenolate Mofetil

oral

DRUG

Methylprednisolone

oral

DRUG

Prednisolone

oral

Trial Locations (9)

Unknown

3 Sites, Beijing

Fuzhou

2 Sites, Guangzhou

Wuhan

Changsha

Shenyang

2 Sites, Shanghai

Chongqing

Hangzhou

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY